References
- World Health Organization. Coronavirus disease (COVID-19) pandemic. 2021 [Accessed 12 May 2021]. Available at: https://www.who.int/covid-19
- Ali T, Vichinsky E, Musallam K, et al. (editors). Guidelines for the management of non-transfusion dependent thalassaemias. 2nd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2013.
- Farmakis D, Giakoumis A, Angastiniotis M, et al. The changing epidemiology of the ageing thalassaemia populations: a position statement of the thalassaemia international federation. Eur J Haematol. 2020;105(1):16–23.
- Karimi M, De Sanctis V. Implications of SARSr-CoV 2 infection in thalassemias: do patients fall into the “high clinical risk” category? Acta Biomed. 2020;91(2):50–56.
- Motta I, De Amicis MM, Pinto VM, et al. SARS-CoV-2 infection in beta thalassemia: preliminary data from the Italian experience. Am J Hematol. 2020;95(8):E198–E199.
- Huang C, Wang Y, Li X, Lancet, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. Erratum: [No authors listed] 2020;395(10223):496.
- Karimi M, Haghpanah S, Azarkeivan A, et al. Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience. Br J Haematol. 2020;190(3):e137–e140.
- Farmakis D, Giakoumis A, Cannon L, et al. COVID-19 and thalassaemia: a position statement of the Thalassaemia International Federation. Eur J Haematol. 2020;105(4):378–386.
- Varelas C, Gavriilaki E, Sakellari I, et al. Hemoglobinopathies and Covid-19: the experience of a center in Northern Greece. [Abstract]. European Haematology Association 2021 Virtual Congress. European Haematology Association Library. Available at: https://library.ehaweb.org/eha/2021/eha2021-virtualcongress/324475/christos.varelas.hemoglobinopathies.and.covid-19.the.experience.of.a.center.in.html
- Covid-19 guidelines. New epidemiological surveillance report 29/08–04/09/2022. Frequently asked questions - answers related to the disease covid-19. [Greek]. [Accessed: 31 May 2021] Available from: eody.gov.gr.
- Anastassopoulou C, Gkizarioti Z, Patrinos GP, et al. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics. 2020;14(1):40.
- Biswas M, Rahaman S, Biswas TK, et al. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2021;64(1):36–47.
- Thakur B, Dubey P, Benitez J, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. 2021;11(1):8562.
- Motta I, Pinto VM, Longo F, et al. COVID 19 and hemoglobinopathies: update of the Italian experience. (Poster 778) Proceedings of the 62nd American Society of Hematology Meeting and Exposition, held in virtual format, December 5–8 202. Blood. 2020;136(Supplement 1):17–18.